NASPAG News

ADVOCACY COMMITTEE UPDATE

The Advocacy Committee continues its hard work in the setting of our current sociopolitical climate and all the things that continue to affect reproductive healthcare. This is particularly important for sexuality and gender minority adolescents and young adults. Below is a summary of the committee’s most recent accomplishments and activities:

• On behalf of NASPAG, the Advocacy Committee signed onto a letter to US Vice President in support of US hosting the International Conference on Population and Development (ICPD+30) in honor of its 30th anniversary. The ICPD Conference Coalition has put together a set of recommendations for the U.S. government to define their robust engagement in the ICPD process. One of these recommendations asks the U.S. government to convene a high-level commemorative event next summer, headlined by Vice President Harris, that celebrates and affirms U.S. commitment to delivering sexual and reproductive health and rights for all through its actions on programs, policy, and funding.

Read More

ACRM Program Chair Letter

Hello NASPAG Family!

The end of the year is a time when many of us reflect on the past year and look forward to the year ahead. I use this time to truly focus on gratitude for all the accomplishments and lessons learned while remaining open to the abundance ahead! There are countless things that I am grateful for in 2023. Although too numerous to count, I give gratitude for the health of my loved ones, my expanding family, and my communities both personal and professional. I am also thankful for the relationships strengthened over the last year, particularly those within the NASPAG community.

Read More

NEW Advocacy Statement on Accessibility and Equity for Opill

 
The North American Society for Pediatric and Adolescent Gynecology (NASPAG) has served as a leader in advocacy for unrestricted, unbiased, and evidence-based reproductive care for adolescents. We recognize and emphasize the potential health, social, and economic implications of mistimed or unplanned pregnancy during adolescence and have previously released a statement supporting the availability of oral progestin-only contraceptive pills to adolescents.

Read the Full Statement Here

JPAG NEWS: LETTER FROM THE EDITOR

As I write this update from JPAG, Thanksgiving 2023 is in the rearview mirror.. As usual, my family gathered at our home, and there were adult kids, a grandchild, the outlaws (daughter-in-law’s parents), and friends who for various reasons will join our gathering. There was much to be grateful for this year, and Thanksgiving Day allows us the tradition of a day honoring gratitude. We are healthy, we have plenty, we are together. The bounty of our home garden once again supplied side dishes of spinach, lettuce, persimmons, apples, various fruit jams and jellies, pickled beets, pickled peppers, and even some tomatoes fresh from the vine. I’m grateful that hubby cooked the turkey. We live in beautiful California, where our Thanksgiving day included high temperatures near 70 degrees; we ate outside All reasons to give thanks. We are reminded by near-tragedies that we are grateful for the safety of relatives who lost their beautiful home and all their possessions this year to a wildfire.

I am immensely grateful to the amazing JPAG Associate Editors (Andrea Bonny, Veronica Gomez-Lobo, and Eveline Roos) who are hardworking, knowledgeable, and wonderfully collegial. I am grateful to the many PAG folks who agree to review manuscripts for JPAG. Without their peer reviews, JPAG would not be thriving. I am grateful for JPAG’s immensely competent, organized, kind and patient Managing Editor, David Newcombe. I am grateful for JPAG’s Elsevier publisher, Andrea Boccelli, who has always been available and helpful, and who is a good friend of NASPAG. I am grateful to the many scholars who contribute manuscripts to JPAG that add to our knowledge about the gynecologic issues that affect our patients. I am grateful for their scientific curiosity, creativity, and vision.

Read More

NASPAG Congratulates All Of Our 2023 PAG Fellows!

NASPAG Position Statement: Comprehensive Sexual Education for Adolescents

NASPAG, like many other major medical organizations, has been disheartened to see limitations placed on the provision of sexual health education to our youth. Comprehensive sexuality education has been shown to better prepare young persons to make informed and healthy decision about their sexual health and sexual health behaviors. In support of the provision of unrestricted, evidence based comprehensive sexual health education to our youth, the NASPAG Advocacy Committee has released a position statement.

Read the full statement

NASPAG'S Response to Texas Senate Bill 8

NASPAG'S Response to Texas Senate Bill 8

NASPAG’s mission is to advocate for the reproductive well-being of children and adolescents and the provision of unrestricted, unbiased, and evidence-based practice of Pediatric and Adolescent Gynecology. The Texas Senate Bill 8 undermines the ability of Pediatric and Adolescent health care providers to align with NASPAG’s mission. This bill impacts critical reproductive health care, which undoubtedly will disproportionately impact those with poorest resources and access to care. This is one of the most restrictive abortions bans in the US, making abortion illegal with no exceptions for rape, sexual abuse, incest, or fetal anomaly diagnosis.  

Read more

NASPAG to host the World Congress in PAG in 2026!

Congratulations!

World Congress image

President's Message 2023-2024

Welcome to NASPAG! 

Whether you are a decades-long NASPAG supporter, a colleague looking for support in caring for your patient, a student learning about pediatric gynecology for the first time,  or anything in between, we are glad you are here! NASPAG is an incredibly vibrant organization filled with members dedicated to improving the reproductive health of youth through evidence-based clinical care, advocacy, education, and research. Our annual meeting energizes us (see you April 4-6 in Orlando), but we know this website is where you need to come to connect and find helpful resources the rest of the year, so welcome! 

Read More

Advocacy Committee Review of Prescription to OTC Switch for Norgestrel

Advocacy Committee Review of Prescription to OTC Switch for Norgestrel

OnTuesday, May 9th, NASPAG was one of 37 different organizations and/or individuals to speak at the Open Public Hearing session of the joint meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee of the FDA. The Advisory Committee was assembled to review the application from HRA Pharma for a "prescription-to-OTC" switch for Norgestrel 0.075mg (Opill) as a progestin-only oral contraceptive. Speakers included several major medical societies, reproductive justice and advocacy organizations, and many youth who boldly shared their personal stories! Out of the 37 speakers, 35 spoke in strong support of the proposal. 

Our Advocacy Committee has been hard at work advocating for this proposal. Shelby Davies, Olga Kciuk and Nichole Tyson attended a confidential briefing by HRA Pharma prior to the public hearing and Shelby Davies spoke on behalf of NASPAG at the public hearing. She shared the remarks previously published by NASPAG, which can be found at the following link:

Read More

Bright Girl Skincare - Exclusive Discount for NASPAG Members

Bright Girl Skincare - Exclusive Discount for NASPAG Members

Hello NASPAG members:

I’m Angela Sanfilippo Casey MD, a double Board-certified dermatologist and daughter of NASPAG member Joseph Sanfilippo MD, MBA. I’m also the founder of Bright Girl skincare for teens/tweens. A line formulated to be clean, gentle, and efficacious...specifically for young skin.
 
I had the pleasure of meeting many of you at the recent NASPAG conference in Nashville. To recognize this organization and its members, I’ve created an online purchase code (NASPAG25) offering our greatest retail discount ever. We’ll provide a 25% discount at checkout, while also donating 25% of all sales back to NASPAG
 
To support this initiative, enter code NASPAG25 at checkout on the Bright Girl website.



Read More

Joint Statement on Adolescents and Young Adults Following Dobbs vs. Jackson

Joint Statement on Adolescents and Young Adults following Dobbs v. Jackson Women’s Health Organization

The Supreme Court’s ruling in Dobbs v. Jackson is an egregious attack on bodily autonomy, removing a pregnant person’s right to autonomous decision making over the most personal and most consequential of life decisions. While this is devastating for all persons, adolescents and young adults will suffer greatly from this decision. This ruling reversed nearly 50 years of legal precedent, issued a direct assault on reproductive justice and the public’s health, and curtailed the status of pregnant persons as free and equal citizens (as noted in the dissenting opinion). We are collectively opposed to this violation of human rights, which will be especially harmful to vulnerable and marginalized populations including adolescents and young adults. We object to any restrictions placed on the reproductive rights of adolescents and young adults. Access to safe abortion is a basic part of comprehensive reproductive health care. This ruling contradicts the broad medical and scientific consensus that abortion is a fundamental component of healthcare, abortion is safe, and abortion is a human right.

Adolescents and young adults already face more barriers than adults in accessing comprehensive reproductive healthcare services and abortion care, such as cost, confidentiality concerns, and limited knowledge and experience seeking healthcare. This ruling means that abortion services will be either obliterated or severely limited in many geographic areas. Remaining avenues for accessing abortion care will be difficult if not impossible for young people, putting their futures, health, and safety at risk. Marginalized individuals and communities and those who experience systemic oppression are also uniquely vulnerable.

Read More

The Future of Abortion Care

The Future of Abortion Care

NASPAG will continue to support and advocate for comprehensive sexual and reproductive care for all.  We continue to oppose legislation that interferes in the patient - health care provider relationship.  Please see this ACOG Message for a summary of strategies that supports access to and provision of abortion care.

Read more

Talking points - COVID-19 Vaccine and Reproductive Health

Talking points - COVID-19 Vaccine and Reproductive Health

With ongoing COVID-19 surges, the need for vaccine uptake among adolescent and young adults is critical to safety and decreasing transmission. Although there is no preferred vaccine formulation, the Pfizer-BioNtech vaccine is the sole formulation that received full FDA approval. Twelve to seventeen-year olds are currently only eligible to receive the Pfizer-BioNtech vaccine. The FDA has also recently approved the Pfizer-BioNtech vaccine for those 5-11 years of age, and it is anticipated that other countries will approve the same in the coming weeks around the world.

Read More

ACRM 2024 - Save the Date!

Our 2024 Annual Clinical Research Meeting will be held on April 4 - 6 in Orlando

Thank you for a tremendous ACRM 2023!